Curative Biosciences, Inc. (CBDX)

Curative Biosciences Cash Flow Statement

Financials in millions USD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Mar 31, 2018	Jun 30, 2017	Jun 30, 2016	Jun 30, 2015	Jun 30, 2014	Jun 30, 2013
Net Income	-0.52	-0.05	-1.66	-3.37	-30	-6.64
Depreciation & Amortization	0	0	0	0	0.04	0
Other Amortization	-	-	-	-	0	0.06
Stock-Based Compensation	0.43	0.02	1.71	1.45	0.16	0.45
Other Operating Activities	0.02	0.02	0.03	1.46	29.35	5.84
Change in Inventory	-	-	-	-	0.05	0.08
Change in Accounts Payable	-0.01	0	0.04	0.09	0.17	-0.05
Change in Other Net Operating Assets	-	-	-0.16	0.3	0.08	0.09
Operating Cash Flow	-0.08	-0.01	-0.03	-0.07	-0.14	-0.16
Capital Expenditures	-	-	-	-	-	-0
Sale (Purchase) of Intangibles	-0.01	-	-	-	-	-
Investing Cash Flow	-0.01	-	-	-	-	-0
Short-Term Debt Issued	-	0.01	0.03	0.07	0.14	0.17
Total Debt Issued	0.1	0.01	0.03	0.07	0.14	0.17
Net Debt Issued (Repaid)	0.1	0.01	0.03	0.07	0.14	0.17
Financing Cash Flow	0.1	0.01	0.03	0.07	0.14	0.17
Net Cash Flow	0	-	-0	0	-	0.01
Free Cash Flow	-0.08	-0.01	-0.03	-0.07	-0.14	-0.16
Free Cash Flow Margin	-	-	-	-	-	-97.47%
Free Cash Flow Per Share	-0.01	-0.00	-0.00	-0.01	-0.04	-2.91
Levered Free Cash Flow	-	-	-	0.77	-0.03	5.94
Unlevered Free Cash Flow	-	-	-	0.77	-0.03	5.94
Change in Net Working Capital	-	-	-	-0.39	-0.06	-0.11

Source: S&P Global Market Intelligence. Standard template. Financial Sources.